NYSE:VMI - New York Stock Exchange, Inc. - US9202531011 - Common Stock - Currency: USD
VALMONT INDUSTRIES (NYSE:VMI) shows strong profitability and reasonable valuation, making it a candidate for GARP investors. Read why it fits Peter Lynch’s strategy.
Softness across all segments and rising costs are likely to ail NDSN's second-quarter fiscal 2025 results.
Valmont (VMI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
ENS' fiscal Q4 net sales increase 7%, driven by solid momentum in the specialty and communications markets.
ENS' fourth-quarter fiscal 2025 results are expected to benefit from the solid performance across its businesses, partly offset by forex woes.
RBC's fourth-quarter fiscal 2025 results are expected to benefit from the commercial aerospace market, partly offset by cost inflation.
Valmont has followed the market’s trajectory closely. The stock is down 5.2% to $322.34 per share over the past six months while the S&P 500 has lost 1%. This was partly driven by its softer quarterly results and might have investors contemplating their next move.
PLUG posts first-quarter 2025 results, wherein its revenues increase 11.1% year over year on growing electrolyzer deliveries and continued demand in material handling.
Infrastructure and agriculture equipment manufacturer Valmont Industries (NYSE:VMI) missed Wall Street’s revenue expectations in Q1 CY2025, with sales flat year on year at $969.3 million. On the other hand, the company’s outlook for the full year was close to analysts’ estimates with revenue guided to $4.1 billion at the midpoint. Its GAAP profit of $4.32 per share was 0.8% below analysts’ consensus estimates.
TTEK's second-quarter fiscal 2025 results reflect growth across each of its segments, driven by solid momentum across end markets.
AXON's first-quarter revenues increase 31.3% year over year, driven by the impressive performance of its Connected Devices and Software & Services segments.
KMT's fiscal third-quarter 2025 revenues decrease 5.7% due to the lackluster performance of the Metal Cutting segment.
EMR's second-quarter fiscal 2025 revenues inch up 1% year over year, driven by strength in its Software and Control segment.
POWL's second-quarter fiscal 2025 revenues increase 9.2% year over year, driven by growth across the electric utility and commercial & other industrial sectors.
POWL's second-quarter fiscal 2025 results are expected to benefit from solid momentum across petrochemical and oil and gas markets, partly offset by cost inflation.
IR's first-quarter 2025 adjusted earnings of 72 cents per share decrease 7.7% year over year.
ITT's Q1 revenues increase 0.3% year over year, driven by connectors growth in the Connect & Control Technologies segment.
PH's fiscal third-quarter sales decrease 2% year over year due to the lackluster performance of the Diversified Industrial segment.
Strength in the Health & Science Technologies segment aids IEX's first-quarter results.
Weakness in both segments weighs on SWK's top line in the first quarter of 2025.
FLS' first-quarter 2025 revenues increase 5.2% year over year, driven by the impressive performance of its Flowserve Flow Control Division unit.
AOS' Q1 sales decline 1.5% due to lower water heater volumes and decreased sales in China.
ZBRA's first-quarter 2025 revenues surge 11.3% year over year, driven by strength in the Asset Intelligence & Tracking and Enterprise Visibility & Mobility segments.
ROP's first-quarter 2025 revenues increase 12% year over year, driven by strength in its Application Software segment.
ALLE's first-quarter revenues increase 5.4% year over year, driven by solid momentum in the non-residential business in the Americas region.
GGG's first-quarter 2025 sales increase 7% year over year due to the higher demand in all its segments.
Q1 revenues in VMI's infrastructure segment decreased roughly 2.4% but achieved higher sales in the agriculture segment.
3M reports adjusted revenue growth of 0.8% year over year in its first-quarter 2025 results.
DHR's first-quarter sales decrease 1% year over year, due to the lackluster performance of its Life Sciences and Biotechnology segments.
Although the revenue and EPS for Valmont (VMI) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.